Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR2 | P30874 | 11/20 | 0.44 |
| ▸ | SLC2A1 | P11166 | 3/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.37 |
| ▸ | MAOA | P21397 | 2/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
| ▸ | MELK | Q14680 | 1/20 | 0.36 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5744944 | 0.88 | KCNH2 (0.46) | SSTR2SLC2A1KCNH2SSTR4 | |
| SCHEMBL5744836 | 0.88 | SSTR2 (0.48) | SSTR2SLC2A1KCNH2 | |
| SCHEMBL6079988 | 0.85 | CYP19A1 (0.45) | SSTR2SLC2A1KCNH2GRM5 | |
| SCHEMBL5744249 | 0.84 | KCNH2 (0.49) | SSTR2SLC2A1KCNH2 | |
| Hydrochloric Acid SCHEMBL5746922 | 0.83 | KCNH2 (0.48) | SSTR2SLC2A1KCNH2 | |
| SCHEMBL6080763 | 0.82 | CNR2 (0.44) | SLC2A1KCNH2MELK | |
| SCHEMBL3253090 | 0.77 | PTPN11 (0.34) | SSTR2SLC2A1KCNH2 | |
| SCHEMBL3253088 | 0.77 | PTPN11 (0.34) | SSTR2SLC2A1KCNH2 | |
| SCHEMBL3246504 | 0.77 | PTPN11 (0.34) | SSTR2SLC2A1KCNH2 | |
| SCHEMBL3246499 | 0.77 | PTPN11 (0.34) | SSTR2SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | GLAXO GROUP LIMITED (GB) | 2006-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060041123-A1 | Antibacterial agents | NQO2, NRDC, IFNG | SSTR2 4859/4885SLC2A1 4409/4885KCNH2 3365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.